DRREDDY Dr. Reddy's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · Nifty 50 weight (est.): 0.89% · F&O lot size: 625DRREDDY lot size: 625 shares per F&O lot for the 3 listed expiries (2026-10-27, 2026-11-23, 2026-12-29). One lot is worth about ₹7.77 lakh at the last underlying price of ₹1,242.50. All F&O lot sizes →
DRREDDY Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
DRREDDY Seasonality month by month since 1996 · adjusted month-end closes
DRREDDY in October: closed the month higher in 18 of 30 years (1996–2025), with a median move of +2.1% and an average of +0.7%.
Years the month closed higher / years with data, and the median monthly move. Past patterns, not a forecast: most months are close to a coin toss.
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about DRREDDY
In the last completed session, Dr. Reddy's Laboratories Ltd. closed +0.85% with futures open interest moving +1.5%. That combination — price rising while OI builds — is classified as a Long Buildup, meaning derivative traders are adding fresh bullish positions into strength rather than merely covering existing shorts. The option PCR of 0.72 is balanced — no clear directional preference from option writers. Max-pain strike at ₹1,200 sits 3.4% below the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Dr. Reddy's Laboratories Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Dr. Reddy's Laboratories Ltd. leans constructive into the next session. The next scheduled earnings report is on 2026-10-23, with the consensus EPS estimate at ₹8.94717. Earnings days routinely override positioning signals — keep an eye on the calendar.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
DRREDDY Option Chain nearest expiry 2026-10-27 · spot 1,242 · EOD 2026-10-19
DRREDDY option chain today (2026-10-27 expiry, NSE data of 2026-10-19): put-call ratio 0.72 · max pain ₹1,200 · highest call OI at ₹1,200 · highest put OI at ₹1,200 · underlying ₹1,242.50. One lot is 625 shares. At-the-money implied volatility 31.2%, IV rank 68 and IV percentile 92 over the past year (range 12.6%–39.7%); 20-day historical volatility 22.3%.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 35%
Δ 0.96
θ -0.6
ν 0
|
1140 |
IV 35%
Δ -0.04
θ -0.4
ν 0
|
|
IV 35%
Δ 0.94
θ -0.7
ν 0
|
1150 |
IV 35%
Δ -0.06
θ -0.5
ν 0
|
|
IV 34%
Δ 0.92
θ -0.8
ν 0
|
1160 |
IV 34%
Δ -0.08
θ -0.5
ν 0
|
|
IV 33%
Δ 0.90
θ -0.9
ν 0
|
1170 |
IV 33%
Δ -0.10
θ -0.7
ν 0
|
|
IV 33%
Δ 0.87
θ -1.0
ν 0
|
1180 |
IV 33%
Δ -0.13
θ -0.8
ν 0
|
|
IV 33%
Δ 0.83
θ -1.1
ν 0
|
1190 |
IV 33%
Δ -0.17
θ -0.9
ν 0
|
|
IV 32%
Δ 0.78
θ -1.2
ν 1
|
1200 R S MP |
IV 32%
Δ -0.22
θ -1.0
ν 1
|
|
IV 32%
Δ 0.73
θ -1.4
ν 1
|
1210 |
IV 32%
Δ -0.27
θ -1.1
ν 1
|
|
IV 31%
Δ 0.67
θ -1.4
ν 1
|
1220 |
IV 31%
Δ -0.33
θ -1.2
ν 1
|
|
IV 31%
Δ 0.61
θ -1.5
ν 1
|
1230 |
IV 31%
Δ -0.39
θ -1.3
ν 1
|
|
IV 31%
Δ 0.54
θ -1.5
ν 1
|
1240 |
IV 31%
Δ -0.46
θ -1.3
ν 1
|
|
IV 31%
Δ 0.47
θ -1.5
ν 1
|
1250 |
IV 31%
Δ -0.53
θ -1.3
ν 1
|
|
IV 31%
Δ 0.40
θ -1.5
ν 1
|
1260 |
IV 31%
Δ -0.60
θ -1.2
ν 1
|
|
IV 31%
Δ 0.33
θ -1.4
ν 1
|
1270 |
IV 31%
Δ -0.67
θ -1.1
ν 1
|
|
IV 31%
Δ 0.27
θ -1.2
ν 1
|
1280 |
IV 31%
Δ -0.73
θ -1.0
ν 1
|
|
IV 31%
Δ 0.22
θ -1.1
ν 1
|
1290 |
IV 31%
Δ -0.78
θ -0.9
ν 1
|
|
IV 32%
Δ 0.18
θ -1.0
ν 0
|
1300 |
IV 32%
Δ -0.82
θ -0.8
ν 0
|
|
IV 32%
Δ 0.14
θ -0.8
ν 0
|
1310 |
IV 32%
Δ -0.86
θ -0.6
ν 0
|
|
IV 32%
Δ 0.11
θ -0.7
ν 0
|
1320 |
IV 32%
Δ -0.89
θ -0.5
ν 0
|
|
IV 32%
Δ 0.08
θ -0.6
ν 0
|
1330 |
IV 32%
Δ -0.92
θ -0.3
ν 0
|
|
IV 33%
Δ 0.07
θ -0.5
ν 0
|
1340 |
IV 33%
Δ -0.93
θ -0.3
ν 0
|
Chain Interpretation
Strategy Builder multi-leg payoff for DRREDDY options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
DRREDDY — frequently asked questions
What is the Dr. Reddy's Laboratories Ltd. share price today?
DRREDDY is trading at ₹1,242.50 (+0.77% vs previous close), per the latest update on this page.
What is the P/E ratio of Dr. Reddy's Laboratories Ltd.?
DRREDDY (Dr. Reddy's Laboratories Ltd.) has a trailing twelve-month P/E ratio of 31.3.
What is the market cap of Dr. Reddy's Laboratories Ltd.?
DRREDDY has a market capitalisation of approximately ₹103,499 crore.
What is the ROE of Dr. Reddy's Laboratories Ltd.?
DRREDDY has a return on equity (ROE) of about 8.8%.
Is DRREDDY near its 52-week high?
DRREDDY is trading -12.2% from its 52-week high of ₹1,414.90 as of 2026-10-19.
What is the RSI of DRREDDY?
The 14-day RSI of DRREDDY is 60.2, which is considered neutral.
Is DRREDDY above its 200-day moving average?
DRREDDY is trading below its 200-DMA of ₹1,244.05 (-0.1% away).
What is the F&O buildup in DRREDDY?
The latest end-of-day derivatives data classifies DRREDDY as Long Buildup (bias: bullish), based on the day's combined price and open-interest change.
What is the max pain and PCR for DRREDDY options?
DRREDDY's option-chain max pain strike is ₹1,200 and its put-call ratio (OI) is 0.72, from the latest end-of-day option chain.
Are FIIs or big investors buying DRREDDY?
Strota tracks every bulk and block deal in DRREDDY with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.